- AU$4.69bn
- AU$4.81bn
- AU$4.93bn
- 52
- 35
- 100
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 52.39 | ||
| PEG Ratio (f) | 0.79 | ||
| EPS Growth (f) | 197.53% | ||
| Dividend Yield (f) | 1.23% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.6 | ||
| Price to Tang. Book | 6.44 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.95 | ||
| EV to EBITDA | 101.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.24% | ||
| Return on Equity | -1.62% | ||
| Operating Margin | 0.44% | ||
Financial Summary
| Year End 31st Jan | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3,509.42 | 3,549.47 | 3,761.91 | 3,417.21 | 4,925.67 | 8,668.5 | 9,390.32 | 8.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -3.45 | n/a | n/a | -52.25 | +116.27 | +488.88 | +24.07 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.
Directors
- Raymond Gunston NEC
- Mark Hooper CEO
- Keith Jeffs CFO
- Kara Mcgowan SEC
- David Manuel NED
- Christine Bartlett NID
- Michael Sammells NID
- Kathryn Spargo NID (69)
- Last Annual
- January 31st, 2025
- Last Interim
- January 31st, 2025
- Incorporated
- July 2nd, 1999
- Public Since
- October 30th, 2002
- No. of Shareholders
- 33,165
- No. of Employees
- 156
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 1,574,676,946
- Address
- Level 6, 2125 Dandenong Road, Clayton, MELBOURNE, 3168
- Web
- https://sigmahealthcare.com.au/
- Phone
- +61 392159215
- Contact
- Gary Woodford
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for SIG
Half Year 2026 Sigma Healthcare Ltd Earnings Release
Similar to SIG
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Althea group
Australian Stock Exchange - SEATS
Anatara Lifesciences
Australian Stock Exchange - SEATS
Argent BioPharma
Australian Stock Exchange - SEATS
FAQ
What is the Sigma Healthcare share price?
As of Today at 23:14 UTC, shares in Sigma Healthcare are trading at AU$2.98. This share price information is delayed by 15 minutes.
How has the Sigma Healthcare share price performed this year?
Shares in Sigma Healthcare last closed at AU$2.98 and the price had moved by +131.01% over the past 365 days. In terms of relative price strength the Sigma Healthcare share price has outperformed the ASX All Ordinaries Index by +127.55% over the past year.
What are the analyst and broker recommendations for Sigma Healthcare?
The overall consensus recommendation for Sigma Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sigma Healthcare dividend yield?
Sigma Healthcare does not currently pay a dividend.
Does Sigma Healthcare pay a dividend?
Sigma Healthcare does not currently pay a dividend.
When does Sigma Healthcare next pay dividends?
Sigma Healthcare does not currently pay a dividend.
How do I buy Sigma Healthcare shares?
To buy shares in Sigma Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sigma Healthcare?
As of the previous close price of AU$2.98, shares in Sigma Healthcare had a market capitalisation of AU$4.69bn.
Where are Sigma Healthcare shares listed?
Here are the trading details for Sigma Healthcare:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: SIG
What kind of share is Sigma Healthcare?
Based on an overall assessment of its quality, value and momentum Sigma Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sigma Healthcare share price forecast for 2025?
The analyst consensus target price for shares in Sigma Healthcare is AU$2.75. That is 7.85% below the last closing price of AU$2.98.
Analysts covering Sigma Healthcare currently have a consensus Earnings Per Share (EPS) forecast of AU$0.05 for the next financial year.
Find out moreWhat is the trend in the Sigma Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sigma Healthcare. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +68.39%.
As of the last closing price of AU$2.98, shares in Sigma Healthcare were trading +33.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sigma Healthcare PE Ratio?
The Sigma Healthcare PE ratio based on its reported earnings over the past 12 months is 52.39. The shares last closed at AU$2.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sigma Healthcare?
Sigma Healthcare's management team is headed by:
- Raymond Gunston - NEC
- Mark Hooper - CEO
- Keith Jeffs - CFO
- Kara Mcgowan - SEC
- David Manuel - NED
- Christine Bartlett - NID
- Michael Sammells - NID
- Kathryn Spargo - NID